(Q73586556)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

chronic lymphocytic leukemia

5 November 2019

main subject

1 reference

Toze CL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Shepherd JD

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Connors JM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Voss NJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Gascoyne RD

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Hogge DE

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Klingemann HG

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Nantel SH

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Nevill TJ

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Phillips GL

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Reece DE

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sutherland HJ

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Barnett MJ

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

605-612

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10734294%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702191

5 November 2019

exact match

0 references

cites work

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Prolonged Initial Remission in Patients with Nodular Mixed Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Survival of young patients with chronic lymphocytic leukemia failing fludarabine therapy: a basis for the use of myeloablative therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Chronic Lymphocytic Leukemia in Younger Adults: Preliminary Results of a Study Based on 454 Patients-IWCLL/Working Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702191

7 January 2021